AMPH · Amphastar Pharmaceuticals, Inc. · Executive Compensation
$25.93
-0.21 (-0.80%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$1.10B
Shares
42.54M
Volume · Oct 20
145.41K
Avg daily vol (3M)
470.54K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Jack Yongfeng Zhang | Chief Executive Officer, President, Chief Scientific Officer and Director | $5,969,742 |
| Mary Ziping Luo | Chief Operating Officer, Chief Scientist and Chairman | $2,976,100 |
| Jason B. Shandell | Former President, General Counsel and Director | $2,924,141 |
| William J. Peters | Chief Financial Officer, Senior Vice President of Finance, Treasurer, and President of International Medication Systems, Limited | $1,957,020 |
| William Peters | Chief Financial Officer, Senior Vice President of Finance, Treasurer, and President of International Medication Systems, Limited | $1,957,020 |
| Rong Zhou | Executive Vice President of Production and President of Armstrong Pharmaceuticals, Inc. | $1,134,468 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Jack Yongfeng Zhang | Chief Executive Officer, President, Chief Scientific Officer and Director | $5,874,707 |
| Mary Ziping Luo | Chief Operating Officer, Chief Scientist and Chairman | $3,033,533 |
| Jason B. Shandell | Former President, General Counsel and Director | $2,584,387 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Jack Yongfeng Zhang | Chief Executive Officer, President, Chief Scientific Officer and Director | $5,755,532 |
| Mary Ziping Luo | Chief Operating Officer, Chief Scientist and Chairman | $2,956,007 |
| Jason B. Shandell | Former President, General Counsel and Director | $2,614,927 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Anthony Pierce | Class III director | Appointed | 2026-07-13 |
| David Gaugh | Class I director | Appointed | 2025-07-21 |
| Michael A. Zasloff | Class II director | Appointed | 2024-06-04 |
| Gayle Deflin | Class II director | Appointed | 2024-06-04 |
| Howard Lee | Class II director | Appointed | 2024-06-04 |
| Mary Ziping Luo | Class II director | Appointed | 2024-06-04 |
| Jacob Liawatidewi | Class I director | Appointed | 2022-08-09 |
| William J. Peters | Class I director | Appointed | 2022-08-09 |
Leadership
- Jack Yongfeng Zhang CEO, Board Member
- William J. Peters CFO, Board Member
- William Peters CFO
- Mary Ziping Luo COO, Board Member
- Jason B. Shandell General Counsel
- Anthony Pierce Board Member
- David Gaugh Board Member
- Gayle Deflin Board Member
- Howard Lee Board Member
- Jacob Liawatidewi Board Member
- Michael A. Zasloff Board Member
Key facts
CIK
1297184
CUSIP
03209R103
13F (30d)
21 filings
21 filers
Visit website
Investor relations